Skip to main content
. 2012 Nov 15;42(1):93–100. doi: 10.3892/ijo.2012.1699

Figure 1.

Figure 1.

Figure 1.

Serum IgG autoantibodies to IGFBP-2. (A and B) Comparisons among normal controls, benign lung disease and patients with lung cancer, and sub-stages. Median levels of serum autoantibodies to IGFBP-2 and interquartile ranges are illustrated by box plot. N, number of subjects; dot, outliers; IGFBP-2, insulin-like growth factor-binding protein-2.